Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05351424

Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology

Led by Columbia University · Updated on 2026-02-12

194

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

V

Varian Medical Systems

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to develop educational media designed specifically for Latinx Spanish-speaking patients undergoing radiation therapy for breast or prostate cancer. The study seeks to improve patient knowledge, treatment adherence, satisfaction, and openness to participating in cancer clinical trials by using culturally and linguistically appropriate audiovisual materials. Researchers also want to find patient and system factors that influence quality radiation therapy and trial enrollment to help reduce healthcare disparities in radiation oncology. Participants will receive either audiovisual videos or written brochures as educational tools about radiation therapy and cancer clinical trials. The study involves two phases of randomization: one for radiation therapy education and another for clinical trial education. Materials will be provided during treatment planning and throughout radiation therapy, which typically lasts several weeks. During the study, participants will complete questionnaires assessing their knowledge of radiation therapy, adherence to treatment, satisfaction, and views on clinical trials at various points before, during, and after radiation therapy. Researchers will track clinical trial enrollment for up to five years. The study includes regular follow-up visits and assessments to monitor outcomes and participant experiences throughout the treatment and post-treatment periods.

CONDITIONS

Brief Title

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Spanish speakers of Latinx background as defined by the U.S. Census Bureau
  • Currently undergoing treatment for breast or prostate cancer, or recently been treated
  • Patients with non-metastatic prostate or breast cancer
  • Histopathologically proven diagnosis of prostate or breast cancer
  • History and physical examination within 28 days prior to enrollment
  • Karnofsky performance status 70 or greater
  • For women of childbearing potential, pregnancy testing performed per institutional guidelines
  • Plan to receive definitive, curative radiation therapy
  • Consultation visit performed with a certified interpreter
Not Eligible

You will not qualify if you...

  • Patient with bilateral deafness and/or blindness
  • Patient with psychosis and/or dementia
  • Clinical or radiological evidence of metastatic disease
  • Prior participation in cancer patient education trial
  • Prior radiation therapy
  • Radiation therapy for sites other than breast or prostate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Treatment

Duration - 4 to 9 weeks

Participants receive educational materials about radiation therapy and cancer clinical trials through audiovisual videos or written brochures to improve knowledge, adherence, satisfaction, and trial enrollment.

1 baseline visit prior to first randomization and 1 visit during CT simulation

Follow-up

Duration - Up to 5 years

Participants are assessed for clinical trial perceptivity and enrollment after completing radiation therapy, with ongoing follow-up for up to 5 years.

1 follow-up visit within 8 to 12 weeks after radiation therapy completion

Trial Site Locations

Total: 2 locations

1

Mount Sinai Medical Center

Miami Beach, Florida, United States, 33140

Actively Recruiting

2

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

C

Christina Chesnakov, MPH

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

4

Similar Trials

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With...

Prostate Cancer

Actively Recruiting

1 location

A Phase 1b Study of 177Lu-PSMA-617 Combined With Liver Direc...

Metastatic Prostate Cancer

Actively Recruiting

1 location

18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Phase III Ac...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here